Skanska signs additional contract for new hospital in Fort Myers, Florida, USA, for USD 60M, about SEK 560M

By Cision
Skanska

Skanska has signed an additional contract with Lee Health for the construction of a new hospital and medical office building in Fort Myers, Florida, USA. The additional contract is worth USD 60M, about SEK 560M, which will be included in the US order bookings for the third quarter of 2026.

The full project contract was amended to include interior build-out finishes, and mechanical, electrical and plumping work associated with the West Bed Tower expansion. The full project scope includes constructing an approximately 38,600 square-meter (416,000-square-foot), five-story hospital, a central energy plant, and an approximately 11,600 square-meter (125,000-square-foot) medical office building which includes an ambulatory surgery center.

Construction began in June 2024 and is scheduled for completion in May 2028.

For further information please contact:

Jessica Wheeler, Communications Director Southeast, Skanska USA, tel +1 919 717 3429

Andreas Joons, Press Officer, Skanska AB, tel +46 76 870 75 51

Direct line for media, tel +46 (0)10 448 88 99

This and previous releases can also be found at www.skanska.com/group.

Skanska Group uses its knowledge and foresight to shape the way people live, work, and connect. We are one of the world's largest construction and project development companies, with 2025 revenue totaling SEK 179 billion. We operate across select markets in the Nordics, Europe and USA. Together with our customers and the collective expertise of our approximately 25,900 teammates, we create innovative and sustainable solutions that support healthy living beyond our lifetime.

https://news.cision.com/skanska/r/skanska-signs-additional-contract-for-new-hospital-in-fort-myers--florida--usa--for-usd-60m--about-s%2Cc4403719

20261002 US additional hospital contract

Image US hospital Fort Myers

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk